|
|
| HOME |
|
|
|
|
CAREERS |
|
Recent News
|
|
Apricus Bio Products
About Apricus Bio
Apricus Biosciences, Inc., a San Diego based revenue-generating pharmaceutical company, has leveraged the flexibility of its clinically-validated NexACT® drug delivery technology to enable multi-route administration of new and improved compounds across numerous therapeutic classes.
Revenues and growth are driven from the sales of the Company's commercial products and out-licensing in certain territories of its product pipeline and NexACT® technology. The company's pipeline includes Vitaros® , approved in Canada for the treatment of erectile dysfunction, Totect the only drug approved in the US for the treatment of anthracycline extravasation, as well as compounds in development from pre-clinical through pre-registration, currently focused on Sexual Dysfunction, Oncology, Dermatology, Autoimmune, Pain, Anti-Infectives, Diabetes and Consumer Healthcare.
The Company also expects to develop and/or acquire and then bring to market additional pharmaceutical products in areas of care that will benefit patient needs worldwide.
| © 2012 Apricus Biosciences, Inc. All Rights Reserved. | Contact Us Terms of Use Agreement Privacy Policy Safe Harbor Subscribe Sitemap |